XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.3

Key Management Personnel Disclosures

12 Months Ended

Jun. 30, 2024

Statement [LineItems]

Key Management Personnel Disclosures

NOTE 23. KEY MANAGEMENT PERSONNEL DISCLOSURES

(a) Directors and key management personnel compensation

		Consolidated
		June 30, 2024 A$				June 30, 2023 A$				June 30, 2022 A$
Short-term employee benefits			2,656,821				1,471,671				1,341,126
Long-term employee benefits			3,861				11,967				13,091
Post-employment benefits			66,891				54,548				47,611
Share-based payments			1,259,571				1,380,074				1,110,757
			3,987,144				2,918,260				2,512,585

(b) Equity instrument disclosures relating to key management personnel

(i) Options provided as remuneration and shares issued on exercise of such options

There were no options provided as remuneration during the fiscal years June 30, 2024, June 30, 2023 and June 30, 2022.

(ii) Shareholding

The numbers of shares in the company held during the financial year by each director of and other key management personnel of the Group, including their personally related parties, are set out below. There were no shares granted during the reporting period as compensation.

						Received during the
		Balance at start				fiscal year				Received during the				Other changes				Balance at end of
		the				on exercise of				fiscal year on the				during the				of the
June 30, 2024		fiscal year				performance rights				exercise of options				fiscal year #				fiscal year
Ordinary shares
Dr Russell Howard			1,113,207				—				—				—				1,113,207
Mr Pete Meyers			2,774,395				500,000				—				—				3,274,395
Mr Marc Voigt			11,247,445				—				—				—				11,247,445
Dr Frédéric Triebel			8,653,764				—				—				—				8,653,764
Ms A Anderson			—				—				—				—				—
Dr F Vogl			—				—				—				—				—
Ms Lis Boyce			—				—				—				—				—
Ms Deanne Miller			3,267,305				—				—				(1,200,000	)			2,067,305
Total ordinary shares			27,056,116				500,000				—				(1,200,000	)			26,356,116
ADSs
Mr Marc Voigt			45				—				—				—				45
Dr Frédéric Triebel			17,061				—				—				—				17,061
Total ADSs			17,106				—				—				—				17,106

# Other changes during the year includes on market acquisitions and/or disposals

						Received during the
		Balance at start				fiscal year				Received during the				Other changes				Balance at end
		of the				on exercise of				fiscal year on the				during the				of the
June 30, 2023		fiscal year				performance rights				exercise of options				fiscal year				fiscal year
Ordinary shares
Dr Russell Howard			1,000,000				113,207				—				—				1,113,207
Mr Pete Meyers			2,274,395				500,000				—				—				2,774,395
Mr Marc Voigt			8,847,445				2,400,000				—				—				11,247,445
Dr Frédéric Triebel			7,753,764				900,000				—				—				8,653,764
Ms Lucy Turnbull			3,284,126				92,966				—				(3,377,092	)*			—
Ms Lis Boyce			—				—				—				—				—
Ms Deanne Miller			2,767,305				600,000				—				(100,000	)#			3,267,305
Total ordinary shares			25,927,035				4,606,173				—				(3,477,092	)			27,056,116
ADSs											—
Mr Marc Voigt			45				—				—				—				45
Dr Frédéric Triebel			17,061				—				—				—				17,061
Total ADSs			17,106				—				—				—				17,106

# Other changes during the year includes on market acquisitions and/or disposals

* This change during the year represents derecognition due to the cessation of the director’s position

						Received during the
		Balance at start				fiscal year				Received during the				Other changes				Balance at end
		of the				on exercise of				fiscal year on the				during the				of the
June 30, 2022		fiscal year				performance rights				exercise of options				fiscal year				fiscal year
Ordinary shares
Dr Russell Howard			750,000				250,000				—				—				1,000,000
Mr Pete Meyers			1,774,395				500,000				—				—				2,274,395
Mr Marc Voigt			8,847,445				—				—				—				8,847,445
Mr Grant Chamberlain			1,728,023				450,000				—				(2,178,023	)*			—
Ms Lucy Turnbull			—				—				—				3,284,126	**			3,284,126
Ms Deanne Miller			2,963,892				600,000				—				(796,587	)#			2,767,305
Dr Frédéric Triebel			6,853,764				900,000				—				—				7,753,764
Total ordinary shares			22,917,519				2,700,000				—				309,516				25,927,035
ADSs
Mr Marc Voigt			45				—				—				—				45
Dr Frédéric Triebel			—				17,061				—				—				17,061
Total ADSs			45				17,061				—				—				17,106

# Other changes during the year includes on market acquisitions and/or disposals

* This change during the year represents derecognition due to the cessation of the director’s position

** This change during the year represents Ms Lucy Turnbull’s shareholding before she became director on February 25, 2022. The shareholding includes 2,981,626 shares held directly and 302,500 shares held indirectly.

(iii) Option holdings

There were no options holdings held and no movements during the fiscal years 2024, 2023 and 2022.

(iv) Performance rights holdings

The number of performance rights over ordinary shares in the parent entity held during the year by each director and other members of key management personnel of the consolidated entity, including their personally related parties, is set out below.

																		Balance at
		Balance at																end
		start of												Other				of the				Vested and
June 30, 2024		the fiscal year				Granted				Exercised				Changes				fiscal year				exercisable				Unvested
Performance rights over ordinary shares
Dr Russell Howard			226,414				178,356				—				—				404,770				141,563				263,207
Mr Pete Meyers			1,666,667				—				(500,000	)			—				1,166,667				—				1,166,667
Mr Marc Voigt			3,600,000				—				—				—				3,600,000				1,200,000				2,400,000
Dr Frédéric Triebel			2,700,000				—				—				—				2,700,000				900,000				1,800,000
Ms Anne Anderson			—				—				—				—				—				—				—
Ms Lis Boyce			—				589,955				—				—				589,955				89,954				500,001
Ms Deanne Miller			1,800,000				—				—				—				1,800,000				600,000				1,200,000
Dr Florian Vogl			—				1,343,856				—				—				1,343,856				—				1,343,856
			9,993,081				2,112,167				(500,000	)			—				11,605,248				2,931,517				8,673,731

																		Balance at
		Balance at																end
		start of												Other				of the				Vested and
June 30, 2023		the fiscal year				Granted				Exercised				Changes				fiscal year				exercisable				Unvested
Performance rights over ordinary shares
Dr Russell Howard			339,621				—				(113,207	)			—				226,414				—				226,414
Mr Pete Meyers			1,000,000				1,166,667				(500,000	)			—				1,666,667				—				1,666,667
Mr Marc Voigt			6,000,000				—				(2,400,000	)			—				3,600,000				—				3,600,000
Dr Frédéric Triebel			3,600,000				—				(900,000	)			—				2,700,000				—				2,700,000
Ms Lucy Turnbull			—				457,832				(92,966	)			(364,866	)*			—				—				—
Ms Lis Boyce			—				—				—				—				—				—				—
Ms Deanne Miller			2,400,000				—				(600,000	)			—				1,800,000				—				1,800,000
			13,339,621				1,624,499				(4,606,173	)			(364,866	)			9,993,081				—				9,993,081

* The change during the year represents derecognition due to the cessation of the director’s position.

June 30, 2022		Balance at start of the fiscal year				Granted				Exercised				Other Changes				Balance at end of the fiscal year				Vested and exercisable				Unvested
Performance Rights over ordinary shares
Dr Russell Howard			250,000				339,621				(250,000	)			—				339,621				—				339,621
Mr Pete Meyers			1,500,000				—				(500,000	)			—				1,000,000				—				1,000,000
Mr Marc Voigt			2,400,000				3,600,000				—				—				6,000,000				1,200,000				4,800,000
Mr Grant Chamberlain			1,350,000				—				(450,000	)			(900,000	)*			—				—				—
Ms Deanne Miller			1,200,000				1,800,000				(600,000	)			—				2,400,000				—				2,400,000
Dr Frédéric Triebel			1,800,000				2,700,000				(900,000	)			—				3,600,000				—				3,600,000
			8,500,000				8,439,621				(2,700,000	)			(900,000	)			13,339,621				1,200,000				12,139,621

* The change during the year represents derecognition due to the cessation of the director’s position.

X

- Definition

The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	immp_StatementLineItems
Namespace Prefix:	immp_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration